Literature DB >> 26837360

[Study on burden of disease in Chongqing, 2010-2013].

Xiaoyan Wen1, Anlong Sun2, Bin Peng3, Xiaolan Xu2, Tao Tan2, Yuchen Xu2, Shan Hu1, Jiangpeng Chen1, Ping Que1.   

Abstract

OBJECTIVE: To analysis the burden of diseases (BOD) and economic burden of disease (EBOD) in Chongqing and provide scientific evidence for effective prevention and control of diseases.
METHODS: The burden of diseases of Chongqing were estimated by use of disability-adjusted life year (DALY) from 2010 to 2013, two-step method was used in the calculation of direct economic burden of diseases. DALY combined with the human capital method were used to measure the indirect economic burden.
RESULTS: From 2010 to 2013, DALY loss by all causes for the residents in Chongqing were 123.90, 127.01, 123.30 and 125.99 person year per thousand persons, respectively. The diseases mainly included non-communicable diseases, accounting for 83%-87%, followed by injure and infectious diseases. The five leading diseases of BOD in Chongqing were respiratory system disease, circulatory system disease, malignant tumor, accidental death, neuropsychiatric disease, respectively. The total economic burden of diseases was 1 621.34 million yuan RMB in 2013. The direct and indirect economic burden of diseases were 794.42 million yuan RMB and 826.92 million yuan RMB, which could be attributed to circulatory system disease, respiratory system diseases, injury, malignant tumor and muscle bones and connective tissue diseases.
CONCLUSION: Respiratory system disease, circulatory system diseases, malignant tumor, and injury have caused heavy burden both in people's health and economic status in Chongqing. It is necessary to take effective measures to prevent and control these diseases.

Entities:  

Mesh:

Year:  2015        PMID: 26837360

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  1 in total

1.  Economic Burden of Malignant Tumors - Yichang City, Hubei Province, China, 2019.

Authors:  Xiaojuan Long; Fangfang Lu; Xianglong Xiang; Jiajuan Yang; Chengzhong Xu; Pei Zhang; Shicheng Yu; Qiqi Wang; Chi Hu
Journal:  China CDC Wkly       Date:  2022-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.